Safety & Pharmacovigilance

Mushroom Solutions' Safety & Pharmacovigilance platform is a next-generation, AI-powered automation solution designed for life sciences organizations seeking to enhance patient safety, ensure global regulatory compliance, and accelerate drug safety reporting across the entire drug lifecycle. By uniting Artificial Intelligence (AI), Machine Learning (ML), Natural Language Processing (NLP), and intelligent automation with deep regulatory expertise, the platform streamlines every stage of the pharmacovigilance process — from initial case intake through to global authority submissions.

The platform integrates seamlessly with existing pharmaceutical infrastructures, including clinical trial databases and partner systems, enabling organizations to monitor, assess, and manage adverse events (AEs) with unmatched efficiency, accuracy, and transparency. It is purpose-built to meet the rigorous regulatory requirements of the life sciences industry, including full alignment with ICH E2B(R3), FDA, and EMA standards.

Core Pharmacovigilance Capabilities

• Case Forms Creation: Capture and manage ADR, ICSR, and SUSAR cases with automated validation for data accuracy and completeness. Streamline data intake from clinical trials, post-market surveillance, literature, and partner systems.
• Narrative Generation: Auto-generate CIOMS-compliant narratives from structured and unstructured data sources using Generative AI and NLP, maintaining consistency, accuracy, and audit readiness across all global submissions.
• Gateway Submissions: Automatically generate E2B (R3) XML safety reports for submission to the FDA, EMA, and other global health authorities, with seamless gateway validation, integration, and schema control.
• Compliance & Reporting: Perform regulatory readiness checks including schema validation, MedDRA version control, WHO-DD mapping, and completeness reviews. Quality controls include duplicate detection, causality verification, and comprehensive audit trails.
• Literature Review: Automatically search PubMed, journals, and regulatory databases by disease, product, or keyword, and link published evidence directly to active safety cases for traceable documentation.
• Case Intake Automation: Extract adverse event information from emails, PDFs, EHRs, and call logs using DocuGenX, Mushroom Solutions' proprietary AI document intelligence engine.
• Signal Detection: Detect emerging safety patterns through AI/ML-driven analytics to empower proactive risk mitigation and timely safety signal management.

Key Benefits

• Seamless Integration: Plug-and-play compatibility with existing pharmaceutical systems, diverse data intake from structured and unstructured sources, and interoperable E2B (R3) XML gateway submissions to global health authorities.
• Global Regulatory Compliance: Full alignment with ICH E2B(R3), FDA, and EMA standards, automated MedDRA version control and WHO-DD mapping, and consistently generated CIOMS-compliant narratives that reduce the risk of human error and regulatory non-compliance.
• Reduced Adverse Event Impact: Early AI/ML-driven signal detection enables proactive risk mitigation before localized issues escalate. High-quality data extraction and duplicate detection improve data integrity, while accelerated reporting reduces manual effort by 40–60%, ensuring serious adverse events such as SUSARs are reported to authorities faster.

Measured Platform Value

• Efficiency: Reduce manual effort by 40–60% through intelligent automation.
• Speed: Accelerate submissions via real-time case linkage and validation.
• Accuracy: Ensure consistent, error-free, and validated safety data across all submissions.
• Compliance: Maintain full alignment with ICH E2B(R3), FDA, and EMA standards at all times.
• Insight: Detect risks early and gain data-driven visibility into global safety trends.

Case Study: Narrative Automation for a Global CRO

• A global Clinical Research Organization (CRO) faced frequent delays and inconsistencies in CIOMS narrative generation due to manual, error-prone workflows, resulting in high compliance risk and operational inefficiency.
• Using Mushroom Solutions' DocuGenX platform, the CRO deployed an AI-powered narrative automation solution combining Generative AI, NLP, and ML to automatically create, validate, and submit narratives aligned with ICH E2B(R3) standards.
• The outcome included 60% faster submissions, greater than 99% narrative accuracy, global regulatory compliance with both FDA and EMA requirements, and a significant reduction in manual workload with improved data utilization.
• The CRO successfully transformed its manual, resource-intensive reporting process into a fully digital, compliant, and intelligent pharmacovigilance workflow.

The Mushroom Solutions pharmacovigilance platform is designed for plug-and-play deployment within existing life sciences infrastructures. Its proprietary DocuGenX AI document intelligence engine underpins case intake automation, while the broader platform supports end-to-end integration with clinical trial databases, EHR systems, partner networks, and global regulatory gateway systems including those of the FDA and EMA.